Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation

Ann Hematol. 2009 Mar;88(3):275-7. doi: 10.1007/s00277-008-0584-7. Epub 2008 Aug 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Azacitidine / therapeutic use
  • Cyclin-Dependent Kinase Inhibitor p15 / genetics*
  • Cytogenetics* / trends
  • DNA Methylation / drug effects*
  • DNA Methylation / genetics
  • Decitabine
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Cyclin-Dependent Kinase Inhibitor p15
  • Decitabine
  • Azacitidine